EUVIMEDEUVIMED entdecken
Crossref

Paeonol alleviates ox-LDL-induced endothelial cell injury by targeting the heme oxygenase-1/phosphoinositide 3-kinase/protein kinase B pathway

Weichong Guo, Han Yang, Wenguang He

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-024-03307-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Weichong Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Nanyang First People's Hospital, Nanyang, 473000, China. Hauptthemen laut MEDLINE: Lipoproteins, LDL, Heme Oxygenase-1, Acetophenones, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: the joint construction project of the Medical Science and Technology Research Program of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoproteins, LDLHeme Oxygenase-1AcetophenonesProto-Oncogene Proteins c-aktHuman Umbilical Vein Endothelial CellsHumansSignal TransductionCell SurvivalApoptosisCell ProliferationPhosphatidylinositol 3-KinasePhosphatidylinositol 3-KinasesCells, CulturedReactive Oxygen SpeciesAtherosclerosis

Stichwörter der Autor:innen

AtherosclerosisFerroptosisHMOX1PI3K/AKT pathwayPaeonol

Substanzen

paeonolLipoproteins, LDLHeme Oxygenase-1oxidized low density lipoproteinAcetophenonesProto-Oncogene Proteins c-aktHMOX1 protein, humanPhosphatidylinositol 3-KinasePhosphatidylinositol 3-KinasesReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Nanyang First People's Hospital, Nanyang, 473000, China.
  • Department of Geriatrics, Nanshi Hospital of Nanyang, Nanyang, 473065, China.
  • Department of Thyroid and Breast Surgery, The Fourth Affiliated Hospital, Guangzhou Medical University, No. 1, Guangming East Road, Zengjiang Street, Zengcheng District, Guangzhou, 511300, China. hwg8012@163.com.

Förderung

  • the joint construction project of the Medical Science and Technology Research Program of Henan Province

Zitieren

APA

Guo, W., Yang, H., & He, W. (2025). Paeonol alleviates ox-LDL-induced endothelial cell injury by targeting the heme oxygenase-1/phosphoinositide 3-kinase/protein kinase B pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03307-0

Vancouver

Guo W, Yang H, He W. Paeonol alleviates ox-LDL-induced endothelial cell injury by targeting the heme oxygenase-1/phosphoinositide 3-kinase/protein kinase B pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03307-0

BibTeX
@article{Guo2025,
  author = {Guo, Weichong and Yang, Han and He, Wenguang},
  title = {Paeonol alleviates ox-LDL-induced endothelial cell injury by targeting the heme oxygenase-1/phosphoinositide 3-kinase/protein kinase B pathway},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-024-03307-0}
}
Kostenlos starten →